Assay replaces Epic Beaker with a unified LIS that manages the entire laboratory lifecycle — clinical pathology, anatomic pathology, microbiology, molecular diagnostics, and reference lab coordination — on a single platform with AI-augmented result interpretation, barcode-tracked chain of custody, and direct integration with the 104 Sentinel detection engines that transform raw laboratory data into clinical intelligence.
Laboratory medicine generates the data that drives the majority of clinical decisions in modern healthcare — yet the information systems supporting it remain among the most fragmented, antiquated, and disconnected components of the hospital technology stack. Specimen mislabeling errors occur at a rate of 1 in 1,000 specimens, resulting in delayed diagnoses, repeated draws, and patient harm. Turnaround times for routine tests remain stubbornly high because manual verification processes create bottlenecks that no amount of analyzer speed can overcome. And the richest diagnostic data in the hospital — trends, patterns, early signals of disease — sits in silos that clinicians can access only through retrospective chart review, not real-time intelligence.
Assay is not an accessory to the EHR. It is the diagnostic engine of the Clarion ecosystem — the platform where raw biological material is transformed into the clinical intelligence that drives every treatment decision, every risk score, and every Sentinel AI detection. Every module below operates on a single, unified data model shared with Clarion Scribe, Clarion Mandate, and the Sentinel detection suite.
A mislabeled specimen is not a clerical inconvenience — it is a diagnostic catastrophe. A blood type assigned to the wrong patient can kill. An unlabeled biopsy can delay a cancer diagnosis by weeks. Assay eliminates these risks through an unbroken barcode chain of custody that begins at the bedside. The phlebotomist scans the patient's wristband, scans the collection tubes, and the system verifies that the right tubes are being drawn for the right orders on the right patient. Every subsequent handoff — from transport to receipt, from receipt to centrifuge, from analyzer to result — requires a scan that confirms identity and timestamps the event. No specimen moves through the laboratory without its custody chain intact.
Clinical pathology is the volume engine of the laboratory — hundreds of thousands of chemistry panels, CBCs, coagulation studies, and urinalyses processed every month. Assay manages the entire CP workflow from order receipt through accessioning, routing to the appropriate analyzer, result capture via instrument interface, delta checking against prior values, auto-verification against configurable rules, and delivery to the ordering provider's inbox. The auto-verification engine is the critical differentiator: 78% of routine chemistry and hematology results meet all verification criteria and are released to the chart without manual technologist review, freeing laboratory staff to focus on the 22% of results that require human judgment.
Anatomic pathology is the most complex laboratory discipline — every specimen follows a unique path through grossing, tissue processing, embedding, microtomy, staining, and sign-out, with potential branches for special stains, immunohistochemistry, and molecular testing. Assay manages this entire workflow with barcode-tracked cassettes and slides, protocol-driven processing rules that trigger the correct cassette count and stain panel based on specimen source and clinical indication, and a pathologist workstation that presents the case with all relevant clinical history, imaging, and prior pathology results in a single view. The sign-out workflow supports synoptic reporting for cancer specimens using CAP-compliant templates, narrative reporting for non-neoplastic cases, and integrated digital pathology for remote consultation and AI-assisted morphometric analysis.
Microbiology is where laboratory data becomes immediately life-saving. A positive blood culture in a septic patient triggers a cascade of clinical decisions — antibiotic selection, escalation of care, infectious disease consultation — that depend on rapid, accurate organism identification and antimicrobial susceptibility reporting. Assay's microbiology module manages the complete culture workflow from inoculation through incubation, colony identification (including MALDI-TOF integration), and automated sensitivity panel generation. Results feed directly into the Clarion Sentinel Sepsis engine, which correlates culture data with clinical indicators to calculate real-time sepsis severity and recommend targeted antibiotic therapy. The Pharma engine simultaneously checks the selected antibiotic against the patient's allergies, renal function, and current medications before the order is signed.
A modern clinical laboratory operates dozens of analyzers from multiple vendors — Roche, Abbott, Siemens, Beckman Coulter, Sysmex, BioMérieux — each with its own interface protocol and data format. Epic Beaker does not interface directly with laboratory instrumentation; it requires separate middleware (often Data Innovations or Orchard) to mediate the connection. Assay includes a built-in middleware layer that speaks ASTM, HL7, and proprietary instrument protocols natively, providing bidirectional communication with analyzers for order download, result upload, QC data capture, and reflex testing rules. This eliminates the cost and complexity of a separate middleware product and reduces the number of systems that must be validated, maintained, and troubleshot when interfaces fail at 3:00 AM.
Manual result verification is the single largest bottleneck in laboratory turnaround time. A medical technologist reviews every result — even the ones that are perfectly normal, perfectly consistent with prior values, and perfectly within the expected range for the patient's clinical context. This made sense in the era of manual testing. It does not make sense when automated analyzers produce results with a coefficient of variation of less than 2%. Assay's auto-verification engine applies configurable rule sets that evaluate each result against delta checks (comparison with prior values), critical value thresholds, linearity limits, instrument QC status, specimen integrity flags (hemolysis, icterus, lipemia), and patient-specific parameters (age, sex, clinical context). Results that pass all rules are released directly to the chart. Results that fail any rule are routed to the technologist's review queue with the specific failing criterion highlighted — so the human review is focused and efficient, not reflexive.
No laboratory performs every test in-house. Specialized assays — molecular panels, rare metabolic studies, esoteric toxicology, genetic testing — are sent to reference laboratories. Managing the send-out workflow — specimen preparation, courier coordination, order transmission, result receipt, and billing reconciliation — is a logistical challenge that consumes disproportionate staff time relative to the test volume. Assay automates the entire send-out lifecycle: when a test is ordered that is not performed in-house, the system identifies the designated reference lab, generates the appropriate requisition, prints specimen-specific packaging and transport instructions, transmits the order electronically via HL7 or FHIR, receives the result, and files it in the patient's chart as if it had been performed locally — complete with the reference lab's methodology, reference ranges, and interpretive comments.
Laboratory quality is measured in three dimensions: analytical quality (are the results accurate?), operational quality (are they timely?), and clinical quality (do they lead to the right decisions?). Assay's analytics engine provides real-time visibility into all three. QC dashboards track Westgard rule violations, peer group comparisons, and trend analysis for every analyzer. Turnaround time dashboards decompose total TAT into its component phases — collection, transport, accessioning, analysis, verification, and reporting — so bottlenecks can be identified and addressed at the specific point of delay. Utilization analytics identify tests that are ordered unnecessarily, ordered in duplicate, or ordered without clinical indication — feeding back into Clarion Mandate's appropriate-use decision support to reduce waste at the point of order.
A 900-bed academic medical center processing 4.2 million laboratory tests per year replaced its combination of Epic Beaker and Data Innovations middleware with Clarion Assay. The built-in instrument interface eliminated the middleware layer entirely, removing 340 annual hours of middleware troubleshooting. The auto-verification engine achieved a 78% auto-release rate for routine chemistry and hematology, freeing an estimated 14,000 medical technologist hours per year for quality improvement, method development, and complex result interpretation. Average stat chemistry turnaround time decreased from 28 minutes to 18 minutes as the manual verification bottleneck was eliminated for the majority of results.
A 320-bed community hospital deployed Assay with full Sentinel Sepsis engine integration. When a blood culture turned positive, Assay's microbiology module triggered immediate organism identification via MALDI-TOF, correlated the result with the patient's clinical data through the Sentinel Sepsis engine, and recommended targeted antibiotic therapy through Clarion Mandate — all within 45 minutes of the positive culture signal. Before deployment, the average time from positive blood culture to appropriate antibiotic adjustment was 6.8 hours. After deployment, it was 2.6 hours. In the first year, the system identified 23 cases where empiric antibiotics were ineffective against the cultured organism — interventions that reduced the average sepsis-related length of stay by 1.4 days and contributed to a measurable reduction in sepsis-related mortality.
I have been a laboratory director for twenty-two years. For twenty of those years, my technologists spent the majority of their time looking at normal results and clicking “verify.” Normal potassium, verify. Normal CBC, verify. Normal coag, verify. Thousands of times a day. Assay gave those hours back. My team now spends their time on the results that actually require a human brain — the unexpected critical value, the discrepant delta check, the specimen with hemolysis interference that needs clinical context to interpret. That is what laboratory professionals were trained to do. That is what they should be doing.
A patient was septic on empiric vancomycin and piperacillin-tazobactam. His blood culture turned positive at 2:00 AM. By 2:42 AM, Assay had identified the organism via MALDI-TOF, Sentinel had correlated it with his clinical trajectory, and Mandate had recommended meropenem based on the anticipated resistance pattern — which the sensitivity panel confirmed eighteen hours later. The ID physician told me she had never received a culture result with a targeted antibiotic recommendation before the organism's sensitivity was even final. She said it felt like the laboratory was practicing medicine alongside her. That is exactly what it should feel like.
See Assay configured for your test menu, your analyzer fleet, and your laboratory workflow.